Zentalis Pharmaceuticals, Inc. short interest in 2022
In 2022, Zentalis Pharmaceuticals, Inc.'s disclosed short interest ran from 6.94% of shares outstanding on 14 Jan 2022 to 11.16% on 30 Dec 2022, a change of +4.22 percentage points. The year's high was 15.13% on 30 Jun 2022 and its low 6.94% on 14 Jan 2022, averaging 10.54% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.75 days on 30 Nov 2022. Full history: Zentalis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.94% (14 Jan 2022)
- End of year
- 11.16% (30 Dec 2022)
- Change
- +4.22 pp
- High
- 15.13% (30 Jun 2022)
- Low
- 6.94% (14 Jan 2022)
- Average
- 10.54%
- Highest days to cover
- 16.75 (30 Nov 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.94% | 11.68 | |
| 31 Jan 2022 | 7.02% | 9.57 | |
| 15 Feb 2022 | 8.04% | 12.53 | |
| 28 Feb 2022 | 8.64% | 10.55 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 8.88% | 11.00 | |
| 31 Mar 2022 | 10.59% | 10.83 | |
| 14 Apr 2022 | 10.63% | 3.80 | |
| 29 Apr 2022 | 9.54% | 5.12 | |
| 13 May 2022 | 10.10% | 6.18 | 10-Q filed, results (8-K) |
| 31 May 2022 | 11.50% | 4.40 | |
| 15 Jun 2022 | 13.45% | 10.67 | |
| 30 Jun 2022 | 15.13% | 8.12 | |
| 15 Jul 2022 | 14.62% | 10.03 | |
| 29 Jul 2022 | 13.54% | 15.02 | |
| 15 Aug 2022 | 10.22% | 7.61 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 10.61% | 10.57 | |
| 15 Sep 2022 | 10.66% | 7.75 | |
| 30 Sep 2022 | 10.53% | 9.11 | |
| 14 Oct 2022 | 10.31% | 11.06 | |
| 31 Oct 2022 | 10.46% | 15.42 | |
| 15 Nov 2022 | 10.13% | 7.11 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 10.60% | 16.75 | |
| 15 Dec 2022 | 9.75% | 12.50 | |
| 30 Dec 2022 | 11.16% | 12.18 |
See also: Zentalis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.